Revenue acceleration
Search documents
Vivos Therapeutics signals continued revenue acceleration amid SCN integration and SAMC expansion plans (NASDAQ:VVOS)
Seeking Alpha· 2025-11-20 01:34
Group 1 - The article does not provide any relevant content regarding company or industry insights [1]
Oracle: 2,200% YoY Total Bookings Growth Implies Multi-Year Revenue Acceleration (ORCL)
Seeking Alpha· 2025-09-16 17:53
The demand outlook for Oracle (NYSE: ORCL ) took center stage in its Q1 FY 2026 earnings release, surging by 2,200% YoY. Some may argue that the stock's 35% rally the next trading day seems premature and that it may already beI'm specialized in fundamental equity research, global macro strategy, and top-down portfolio construction. I'm a senior analyst at a multi-strategy hedge fund with 7 years of experience. I graduated from UCLA with a degree of Business Economics and UMich Ross School of Business with a ...